Lexpos News

/Lexpos News

Legislation restricting the sale and supply of gonadotrophin-releasing hormone analogues extended

Last week the Government made the the Medicines (Gonadotrophin-Releasing Hormone Analogues) (Emergency Prohibition) (Extension) Order 2024, which has the effect of extending the ban, which was due to expire. The ban has been extended until 26 November 2024. The Secretary of State has expressed the intention to make the ban permanent, but can only do [...]

The post Legislation restricting the sale and supply of gonadotrophin-releasing hormone analogues extended appeared first on Community Pharmacy England.

By |August 30th, 2024|Lexpos News|Comments Off on Legislation restricting the sale and supply of gonadotrophin-releasing hormone analogues extended

Medicine Supply Notification: Naloxone (Nyxoid® ) 1.8mg/0.1ml nasal spray unit dose

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Naloxone (Nyxoid®) 1.8mg/0.1ml nasal spray unit dose MSN/2024/093 Tier 2 – medium impact Date of issue: 28th August 2024 Naloxone (Nyxoid®) 1.8mg/0.1ml nasal spray unit dose is out of stock until w/c 30th September 2024. Naloxone 1.26mg/0.1ml nasal spray unit dose [...]

The post Medicine Supply Notification: Naloxone (Nyxoid® ) 1.8mg/0.1ml nasal spray unit dose appeared first on Community Pharmacy England.

By |August 28th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Naloxone (Nyxoid® ) 1.8mg/0.1ml nasal spray unit dose

Drug Tariff Watch – September 2024

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 September 2024. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – September 2024 appeared first on Community Pharmacy England.

By |August 28th, 2024|Lexpos News|Comments Off on Drug Tariff Watch – September 2024

MHRA Class 4 Medicines Defect Information: Ponstan 250mg Capsules & 500mg Tablets (Chemidex Pharma Ltd)

Class 4 Medicines Defect Information: Ponstan 250mg Capsules & 500mg Tablets (Chemidex Pharma Ltd) Drug alert number: EL (24)A/340 Date issued: 27 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Ponstan 250mg Capsules & 500mg Tablets (Chemidex Pharma Ltd) Company name: Chemidex Pharma Ltd [...]

The post MHRA Class 4 Medicines Defect Information: Ponstan 250mg Capsules & 500mg Tablets (Chemidex Pharma Ltd) appeared first on Community Pharmacy England.

By |August 27th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Ponstan 250mg Capsules & 500mg Tablets (Chemidex Pharma Ltd)

Medicine Supply Notification: Isosorbide mononitrate 60mg modified-release tablets and capsules updated

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Isosorbide mononitrate 60mg modified-release tablets and capsules. MSN/2024/092 Tier 2 – medium impact Date of issue: 17th September 2024 Chemydur® 60XL tablets are out of stock until late September 2024. Monomax® XL 60mg tablets are out of stock until early October [...]

The post Medicine Supply Notification: Isosorbide mononitrate 60mg modified-release tablets and capsules updated appeared first on Community Pharmacy England.

By |August 27th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Isosorbide mononitrate 60mg modified-release tablets and capsules updated